Status | Study |
Recruiting |
Study Name: Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis Condition: Contact Dermatitis Date: 2017-03-15 Interventions: Drug: BBI-2000 Experimental |
Enrolling by invitation |
Study Name: A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers Condition: Contact Dermatitis Date: 2016-02-19 Interventions: Drug: PDC-APB Other Name: Acti |
Recruiting |
Study Name: The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population Condition: Dermatitis, Contact Date: 2015-11-16 Interventions: Other: Organic, Unrefined Coconut Oil Othe |
Withdrawn |
Study Name: Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study Condition: Contact Dermatitis Date: 2014-01-02 Interventions: Biological: Mercury, Aluminum, Palladium T.R.U.E. Test metal allergen panels containing ascending doses |
Completed |
Study Name: Clinical Evaluation of Lyral® Dose Response Study Condition: Contact Dermatitis Date: 2014-01-02 Interventions: Biological: Lyral® T.R.U.E. Test allergen panel (0.40 mg/cm^2, 0.20 mg/cm^2, 0.10 mg/cm^2 and negat |
Enrolling by invitation |
Study Name: Bariederm Cream in Chronic Contact Dermatitis Condition: Contact Dermatitis Date: 2013-12-22 Interventions: Device: bariederm cream patients are asked to apply twice a day a barrier cream on their hands for 3 wee |
Completed |
Study Name: Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents Condition: Allergic Contact Dermatitis Date: 2013-02-20 Interventions: Drug: T.R.U.E. Test Panel 3.2 Surgical tape containing 12 polyester allergen patches. |
Enrolling by invitation |
Study Name: Immune Reactions in Contact Dermatitis Affected Skin Condition: Allergic Contact Dermatitis Date: 2012-03-02 Interventions: Other: Patch tests Patch tests for allergic reaction |
Completed |
Study Name: Assess Itch Behavior in Nickel Sulphate Sensitized Volunteers Condition: Allergic Contact Eczema Date: 2012-02-06 Interventions: Drug: Adventan® (methylprednisolone aceponate 0,1%) Doses: 1/4 FTU (Finger Tip Unit) during 5 days |
Enrolling by invitation |
Study Name: Nickel Desensitization Using Topical Therapy Condition: Allergic Contact Dermatitis Date: 2011-04-13 Interventions: Drug: Calcipotriol, Betamethasone, Calcipotriol & Betamethasone All study patients will be randomize |